News Article
Satiety hormone may decrease risk of Alzheimer's disease
31 Jan 2019

Research, published in Neurobiology of Aging, suggests that individuals with high levels of the satiety hormone, cholecystokinin, may have a lower risk of developing Alzheimer's disease.

Science Daily